SR One and Oxbridge Biotech Roundtable has launched OneStart, a $163,000 prize for medical technology entrepreneurs.
GlaxoSmithKline’s venture capital division, SR One, and Oxbridge Biotech Roundtable (OBR) are launching a £100,000 ($163,000) cash prize competition, OneStart, for university graduates developing medical technology in drug discovery, medical devices, diagnostics or health IT.
The competition is open to anyone under the age of 35 who has been enrolled in a European University of business school within the last 12 months and will launch in January 2013.
SR One recently invested in Bicycle Therapeutics, a UK-based biotherapeutics startup spun out of…
